According to Anavex Life Sciences 's latest financial reports and stock price the company's current number of shares outstanding is 82,077,815. At the end of 2023 the company had 82,077,815 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 82.07 M | 5.26% |
2022 | 77.97 M | 2.6% |
2021 | 75.99 M | 18.2% |
2020 | 64.29 M | 17.38% |
2019 | 54.77 M | 18.23% |
2018 | 46.32 M | 5.57% |
2017 | 43.88 M | 14.3% |
2016 | 38.39 M | 13.02% |
2015 | 33.97 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Ligand Pharmaceuticals LGND | 17,380,000 | -78.82% | ๐บ๐ธ USA |
Corcept Therapeutics
CORT | 102,014,000 | 24.29% | ๐บ๐ธ USA |
Palatin Technologies PTN | 14,097,757 | -82.82% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | 189,644,000 | 131.05% | ๐บ๐ธ USA |